Inactive Instrument

VISD GP Stock Swiss Exchange

Equities

OXVMG

FR0011067669

Medical Equipment, Supplies & Distribution

End-of-day quote Swiss Exchange
- EUR - Intraday chart for VISD GP
Sales 2021 7.18M 7.68M Sales 2022 14.44M 15.44M Capitalization 98.55M 105M
Net income 2021 -4M -4.28M Net income 2022 -5M -5.35M EV / Sales 2021 1.38 x
Net cash position 2021 1.62M 1.73M Net Debt 2022 3.26M 3.48M EV / Sales 2022 7.05 x
P/E ratio 2021
-1.33 x
P/E ratio 2022
-22.7 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 99.97%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 34 Jan. 21
Investor Relations Contact - -
Corporate Secretary - 22-03-31
Members of the board TitleAgeSince
Chairman - -
Director/Board Member - -
Corporate Secretary - 22-03-31
More insiders
Founded in 2007, Visiomed Group SA relies on a long experience to innovative healthcare technologies and services that will shape tomorrow's health and prevention. The Group now has focused its activities on the Middle East since 2021 with the acquisition of Smart Salem, the first digital medical analysis centre accredited by the Dubai Health Authority (DHA) in the United Arab Emirates, 100% owned by Visiomed Group SA. Visiomed Group SA is also stepping up its development in the region, with the creation of Smart Health, a joint venture which will drive the deployment of the group's innovative centers in Saudi Arabia.
More about the company